Cynthia Perettie
Plus aucun poste en cours
Profil
Cynthia Perettie served as the Chief Executive Officer at Foundation Medicine, Inc. from 2019 to 2021.
Prior to that, she worked at Genentech, Inc. as the Vice President & Global Head-Regulatory Operations.
Perettie received her undergraduate degree from State University of New York College at Potsdam and her graduate degree from St. Mary's College of California.
Anciens postes connus de Cynthia Perettie
| Sociétés | Poste | Fin |
|---|---|---|
| FOUNDATION MEDICINE INC | Directeur Général | 06/04/2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Conseiller Juridique Général | - |
Formation de Cynthia Perettie
| State University of New York College at Potsdam | Undergraduate Degree |
| St. Mary's College of California | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Foundation Medicine, Inc.
 Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. The company was founded on January 10, 2010 and is headquartered in Cambridge, MA. | Health Services |
